You can buy or sell CASI and other stocks, options, and ETFs commission-free!
CASI Pharmaceuticals, Inc. Common Stock, also called CASI Pharmaceuticals, is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong and Macau. Its products include ZEVALIN, EVOMELA and MARQIBO. CASI Pharmaceuticals was founded in 1991 and is headquartered in Rockville, MD. The listed name for CASI is CASI Pharmaceuticals, Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Mar 16, Pre-Market